MedPath

CANCER RESEARCH NETWORK

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery

Phase 2
Conditions
Breast Cancer
First Posted Date
2005-11-10
Last Posted Date
2007-04-04
Lead Sponsor
Cancer Research Network
Target Recruit Count
48
Registration Number
NCT00251329
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Baptist Cancer Institute, Jacksonville, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

Mount Sinai Comprehensice Cancer Center, Miami, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

Oncology /Hematology Associates of Florida, Miami, Florida, United States

and more 3 locations

A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer

Phase 2
Completed
Conditions
Metastatic Breast Cancer
First Posted Date
2005-09-22
Last Posted Date
2012-02-14
Lead Sponsor
Cancer Research Network
Target Recruit Count
18
Registration Number
NCT00214864
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Cancer Research Network, Inc., Plantation, Florida, United States

An Observational Study of Current Practice Pattern on the Treatment of Women With Metastatic Breast Cancer Whose Tumors Overexpress Her2neu

Completed
Conditions
Breast Cancer
First Posted Date
2005-09-12
Last Posted Date
2012-02-14
Lead Sponsor
Cancer Research Network
Target Recruit Count
94
Registration Number
NCT00153218
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Pittsburgh Cancer Institute Magee-Womans Hospital, Pittsburgh, Pennsylvania, United States

๐Ÿ‡บ๐Ÿ‡ธ

Cancer Research Network, Inc., Plantation, Florida, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath